Peter Harris

Professor

Mayo Clinic Rochester

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Peter Harris is a Professor at Mayo Clinic Rochester in the United States. His research focuses on genetic and clinical aspects of kidney diseases, particularly autosomal dominant polycystic kidney disease (ADPKD) and kidney stone risk. Recent articles highlight his work on the pathogenicity of genetic variants, multiomics studies, and clinical guidelines for the management of kidney disorders.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (10)

Berenice Gitomer

Professor

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

Matthew Breeggemann

University of California, San Francisco

UNITED STATES

View details

Albert C. M. Ong

University of Sheffield Medical School

UNITED KINGDOM

View details

Kristen Nowak

Associate Professor

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Harris

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Functional Analysis of a De Novo Monoallelic NEK8 Variant Supports Pathogenicity for a Polycystic Kidney Disease Phenotype

A Multiomics Study of Circulating Proteins and Kidney Stone Risk

KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary

Association between Kidney Stones and CKD

DNA methyltransferase 1 (DNMT1) promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease

Biomarkers of Kidney Disease Progression in ADPKD

How We Treat Primary Hyperoxaluria Type 1

State of the Science and Ethical Considerations for Preimplantation Genetic Testing for Monogenic Cystic Kidney Diseases and Ciliopathies

Activation of PIEZO1 Attenuates Kidney Cystogenesis In Vitro and Ex Vivo

Genetic Spectrum of Polycystic Kidney and Liver Diseases and the Resulting Phenotypes

Experimental Models of Polycystic Kidney Disease: Applications and Therapeutic Testing

Protein Kinase A Downregulation Delays the Development and Progression of Polycystic Kidney Disease

<i>PKD1</i> Compared With <i>PK</i> <i>D2</i> Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies.

mtor Haploinsufficiency Ameliorates Renal Cysts and Cilia Abnormality in Adult Zebrafish tmem67 Mutants

Collaborators (10)

Berenice Gitomer

Matthew Breeggemann

Albert C. M. Ong

Kristen Nowak

Michelle McGowan

Ellen Bendel-Stenzel

Samir Babayev

Vicente Torres

Caroline Sussman

Gregory Tasian

Make your next move.